Centerline Biomedical Appoints Jim Dillon President and Chief Executive Officer
CLBNCLEVELAND--(BUSINESS WIRE)--Centerline Biomedical, Inc. (“Centerline”), an innovative leader in cardiovascular navigation and visualization systems, announced the appointment of Jim Dillon as President and Chief Executive Officer (CEO) and a member of its board of directors. He will assume his responsibilities on August 18, 2025. Mr. Dillon succeeds Gulam Khan, who has served as CEO since October 2022. Mr. Khan led Centerline Biomedical through a period of portfolio development. During his tenu
August 18, 2025Management
Read more →